CrackitToday App

Coartem Baby : First Malaria Drug for Infants

Kumari Sonali

Coartem Baby : First Malaria Drug for Infants

Switzerland has approved Coartem Baby, the first-ever malaria treatment for newborns and infants, developed by Novartis. Eight African nations are expected to follow with fast-track approvals.A new pediatric formulation of artemether-lumefantrine, named Coartem Baby, specifically designed for infants weighing 2–5 kg (newborns to under 6 months). Developed by Novartis, in collaboration with Medicines for Malaria Venture (MMV) and other global health partners.Objective is to close the treatment gap for malaria in the most vulnerable age group — newborns and very young infants, previously excluded from clinical trials and vaccination coverage.

...Read more on our test console

...Read these too

  • Lenacapavir Drug

    Lenacapavir Drug: The United States Food and Drug Administration (FDA) approved Lenacapavir (LEN), the most promising HIV prevention medicine to be made so far. Lenacapavir is an antiretroviral medicine that…

  • Blue Baby Syndrome

    Blue Baby Syndrome: High nitrate levels have been found in the groundwater of 440 districts across India, which can cause health issues like blue baby syndrome in infants and are…

  • Drug Repurposing

    Drug Repurposing: Researchers who have been working in the field of drug repurposing have found the repurpose potential of an antidepressant drug for cancer management. Drug Repurposing is the technique…